Innovating Works

reMYND

A stranger
PANA: PROMOTING ACTIVE AGEING FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER S DISEASE AT ULTRA EARLY STAGES. reMYND NV participó en un H2020 H2020-NMP-2014-2015 Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and...
2016-03-04 - 2021-08-31 | financed
NPLAST: NPlast A neuroscience school that aims to preserve and restore neuroplasticity in brain disorders reMYND NV participó en un FP7 Brain disorders impose an increasing economical and social burden in the member states of the European Union (EU). For most neurodegenerativ...
financed
AGEDBRAINSYSBIO: SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING reMYND NV participó en un FP7 In spite of valuable approaches applied to get a broad understanding of genetic, epidemiologic and molecular and system-level biological pri...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.